{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:47:36Z","timestamp":1782604056247,"version":"3.54.5"},"reference-count":140,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>The presence of maternal Anti-Ro\/Anti-La antibodies causes a passively acquired autoimmunity that may be associated with serious fetal complications. The classic example is the autoimmune-mediated congenital heart block (CHB) which is due in most cases to the transplacental passage of Anti-Ro\/Anti-La antibodies. The exact mechanisms through which these pathologic events arise are linked to disturbances in calcium channels function, impairment of calcium homeostasis and ultimately apoptosis, inflammation and fibrosis. CHB still represents a challenging diagnosis and a source of debate regarding the best management. As the third-degree block is usually irreversible, the best strategy is risk awareness and prevention. Although CHB is a rare occurrence, it affects one in 20,000 live births, with a high overall mortality rate (up to 20%, with 70% of in utero deaths). There is also concern over the lifelong consequences, as most babies need a pacemaker. This review aims to offer, apart from the data needed for a better understanding of the issue at hand, a broader perspective of the specialists directly involved in managing this pathology: the rheumatologist, the maternal\u2013fetal specialist and the cardiologist. To better illustrate the theoretical facts presented, we also include a representative clinical case.<\/jats:p>","DOI":"10.3390\/diagnostics10070478","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T11:03:23Z","timestamp":1594724603000},"page":"478","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["A Broader Perspective on Anti-Ro Antibodies and Their Fetal Consequences\u2014A Case Report and Literature Review"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4539-5259","authenticated-orcid":false,"given":"Mihaela Roxana","family":"Popescu","sequence":"first","affiliation":[{"name":"Cardiology Department, Elias University Hospital, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 011461 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Dudu","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, \u201cDr Carol Davila\u201d Central Emergency University Military Hospital, 010825 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciprian","family":"Jurcut","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, \u201cDr Carol Davila\u201d Central Emergency University Military Hospital, 010825 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca Marina","family":"Ciobanu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Filantropia Clinical Hospital, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 011171 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4302-629X","authenticated-orcid":false,"given":"Ana-Maria","family":"Zagrean","sequence":"additional","affiliation":[{"name":"Division of Physiology and Neuroscience, Department of Functional Sciences, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca Maria","family":"Panaitescu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Filantropia Clinical Hospital, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 011171 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"9479","DOI":"10.1073\/pnas.85.24.9479","article-title":"Molecular analysis of the 60-kDa human Ro ribonucleoprotein","volume":"85","author":"Deutscher","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1073\/pnas.0832411100","article-title":"A lupus-like syndrome develops in mice lacking the Ro 60-kDa protein, a major lupus autoantigen","volume":"100","author":"Xue","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1172\/JCI115003","article-title":"Molecular definition and sequence motifs of the 52-kD component of human SS-A\/Ro autoantigen","volume":"87","author":"Chan","year":"1991","journal-title":"J. Clin. Investig."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Higgs, R., Lazzari, E., Wynne, C., Gabhann, J.N., Espinosa, A., Wahren-Herlenius, M., and Jefferies, C.A. (2010). Self protection from anti-viral responses\u2014Ro52 promotes degradation of the transcription factor IRF7 downstream of the viral toll-like receptors. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0011776"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.4049\/jimmunol.181.3.1780","article-title":"The E3 ubiquitin ligase Ro52 negatively regulates IFN-\u03b2 production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3","volume":"181","author":"Higgs","year":"2008","journal-title":"J. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/jb\/mvp127","article-title":"Ro52-mediated monoubiquitination of IKK\u03b2 down-regulates NF-\u03baB signalling","volume":"146","author":"Wada","year":"2009","journal-title":"J. Biochem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1084\/jem.20091507","article-title":"Vicious circle: Systemic autoreactivity in Ro52\/TRIM21-deficient mice","volume":"206","author":"Bolland","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/1521-4141(200010)30:10<2782::AID-IMMU2782>3.0.CO;2-9","article-title":"Anti-SSA\/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block","volume":"30","author":"Eftekhari","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1083\/jcb.200601026","article-title":"Epstein-Barr virus noncoding RNAs are confined to the nucleus, whereas their partner, the human La protein, undergoes nucleocytoplasmic shuttling","volume":"173","author":"Fok","year":"2006","journal-title":"J. Cell Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.molcel.2011.09.011","article-title":"Autoantigen la promotes efficient RNAi, antiviral response, and transposon silencing by facilitating multiple-turnover RISC catalysis","volume":"44","author":"Liu","year":"2011","journal-title":"Mol. Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/art.10561","article-title":"Evidence-based guidelines for the use of immunologic tests: Antinuclear antibody testing","volume":"47","author":"Solomon","year":"2002","journal-title":"Arthritis Rheum."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2013-203863","article-title":"International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies","volume":"73","author":"Damoiseaux","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaut.2016.06.016","article-title":"A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus","volume":"74","author":"Lazzaroni","year":"2016","journal-title":"J. Autoimmun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2013.11.001","article-title":"A comprehensive review of autoantibodies in primary Sj\u00f6gren\u2019s syndrome: Clinical phenotypes and regulatory mechanisms","volume":"51","author":"Kyriakidis","year":"2014","journal-title":"J. Autoimmun."},{"key":"ref_15","first-page":"686","article-title":"Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sj\u00f6gren\u2019s syndrome","volume":"30","author":"Retamozo","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar3763","article-title":"Clinical significance of antibodies to Ro52\/TRIM21 in systemic sclerosis","volume":"14","author":"Hudson","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/rheumatology\/kev300","article-title":"Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease","volume":"55","author":"Gunnarsson","year":"2016","journal-title":"Rheumatology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Primary Sj\u00f6gren\u2019s Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.curtheres.2014.06.004","article-title":"The prevalence of antinuclear antibodies in the general population of china: A cross-sectional study","volume":"76","author":"Guo","year":"2014","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/art.34380","article-title":"Prevalence and sociodemographic correlates of antinuclear antibodies in the United States","volume":"64","author":"Satoh","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/s10165-008-0028-1","article-title":"Prevalence of disease-specific antinuclear antibodies in general population: Estimates from annual physical examinations of residents of a small town over a 5-year period","volume":"18","author":"Hayashi","year":"2008","journal-title":"Mod. Rheumatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/art.39214","article-title":"Prediction of Sj\u00f6gren\u2019s syndrome years before diagnosis and identification of patients with early onset and severe disease course by autoantibody profiling","volume":"67","author":"Theander","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/acr.24130","article-title":"2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Care Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Wainwright, B., Bhan, R., Trad, C., Cohen, R., Saxena, A., Buyon, J., and Izmirly, P. (2019). Autoimmune-mediated congenital heart block. Best Practice and Research: Clinical Obstetrics and Gynaecology, Bailliere Tindall Ltd.","DOI":"10.1016\/j.bpobgyn.2019.09.001"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIRCULATIONAHA.111.033894","article-title":"Maternal and fetal factors associated with mortality and morbidity in a multi-racial\/ethnic registry of anti-SSA\/Ro-associated cardiac neonatal lupus","volume":"124","author":"Izmirly","year":"2011","journal-title":"Circulation"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1161\/CIRCULATIONAHA.107.735118","article-title":"Perinatal outcome of fetal atrioventricular block one-hundred-sixteen cases from a single institution","volume":"118","author":"Lopes","year":"2008","journal-title":"Circulation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1542\/peds.106.1.86","article-title":"Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn","volume":"106","author":"Eronen","year":"2000","journal-title":"Pediatrics"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1161\/CIRCULATIONAHA.111.041970","article-title":"Isolated atrioventricular block in the fetus: A retrospective, multinational, multicenter study of 175 patients","volume":"124","author":"Eliasson","year":"2011","journal-title":"Circulation"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.amjcard.2015.03.051","article-title":"Isolated complete heart block in the fetus","volume":"116","author":"Ho","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrrheum.2015.29","article-title":"The clinical spectrum of autoimmune congenital heart block","volume":"11","author":"Izmirly","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1080\/14767058.2017.1326904","article-title":"Maternal autoimmune disorders and fetal defects","volume":"Volume 31","author":"Panaitescu","year":"2018","journal-title":"Journal of Maternal-Fetal and Neonatal Medicine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1016\/j.jacc.2010.02.042","article-title":"The importance of the level of maternal anti-Ro\/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus: A prospective study of 186 antibody-exposed fetuses and infants","volume":"55","author":"Jaeggi","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/ard.2008.088054","article-title":"Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus","volume":"68","author":"Rivera","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJM198704303161807","article-title":"The neonatal lupus syndrome associated with U1RNP (nRNP) antibodies","volume":"316","author":"Provost","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_36","first-page":"139","article-title":"Cardiac manifestations of neonatal lupus erythematosus: Guidelines to management, integrating clues from the bench and bedside","volume":"5","author":"Buyon","year":"2009","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/art.1780400223","article-title":"Monozygotic twins discordant for congenital complete heart block","volume":"40","author":"Cooley","year":"1997","journal-title":"Arthritis Rheum."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/art.11430","article-title":"Immunohistologic evidence supports apoptosis, lgG deposition, and novel macrophage\/fibroblast crosstalk in the pathologic cascade leading to congenital heart block","volume":"50","author":"Clancy","year":"2004","journal-title":"Arthritis Rheum."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fcvm.2019.00054","article-title":"Autoimmune calcium channelopathies and cardiac electrical abnormalities","volume":"6","author":"Qu","year":"2019","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/BOR.0000000000000414","article-title":"Progress in the pathogenesis and treatment of cardiac manifestations of neonatal lupus","volume":"29","author":"Izmirly","year":"2017","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S1050-1738(00)00059-1","article-title":"Molecular and ionic basis of congenital complete heart block","volume":"10","author":"Boutjdir","year":"2000","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_42","first-page":"2413","article-title":"Impaired clearance of apoptotic cardiocytes is linked to anti-SSA\/Ro and -SSB\/La antibodies in the pathogenesis of congenital heart block","volume":"116","author":"Clancy","year":"2006","journal-title":"J. Clin. Invest."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.4049\/jimmunol.165.9.5345","article-title":"Anti-SSA\/Ro and Anti-SSB\/La Autoantibodies Bind the Surface of Apoptotic Fetal Cardiocytes and Promote Secretion of TNF-\u03b1 by Macrophages","volume":"165","author":"Askanase","year":"2000","journal-title":"J. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autrev.2004.04.003","article-title":"Autoantibody-associated congenital heart block: TGFh and the road to scar","volume":"4","author":"Buyon","year":"2004","journal-title":"Autoimmun. Rev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.4049\/jimmunol.171.6.3253","article-title":"Cytokine polymorphisms and histologic expression in autopsy studies: Contribution of TNF-\u03b1 and TGF-\u03b21 to the pathogenesis of autoimmune-associated congenital heart block","volume":"171","author":"Clancy","year":"2003","journal-title":"J. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4049\/jimmunol.1800357","article-title":"Siglec-1 macrophages and the contribution of IFN to the development of autoimmune congenital heart block","volume":"202","author":"Clancy","year":"2019","journal-title":"J. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Hedlund, M., Thorlacius, G.E., Ivanchenko, M., Ottosson, V., Kyriakidis, N., Lagnefeldt, L., Tingstr\u00f6m, J., Sirsj\u00f6, A., Bengtsson, A.A., and Aronsson, E. (2020). Type i IFN system activation in newborns exposed to Ro\/SSA and La\/SSB autoantibodies in utero. RMD Open.","DOI":"10.1136\/rmdopen-2019-000989"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1203\/00006450-199807000-00002","article-title":"Serum and immunoglobulin G from the mother of a child with congenital heart block induce conduction abnormalities and inhibit L-type calcium channels in a rat heart model","volume":"44","author":"Boutjdir","year":"1998","journal-title":"Pediatr. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/01.RES.80.3.354","article-title":"Arrhythmogenicity of lgG and anti-52-kD SSA\/Ro affinity-purified antibodies from mothers of children with congenital heart block","volume":"80","author":"Boutjdir","year":"1997","journal-title":"Circ. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jaut.2009.06.005","article-title":"Congenital heart block: Identification of autoantibody binding site on the extracellular loop (domain I, S5-S6) of \u03b11D L-type Ca channel","volume":"34","author":"Karnabi","year":"2010","journal-title":"J. Autoimmun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrcardio.2017.61","article-title":"Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias","volume":"14","author":"Lazzerini","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"194","DOI":"10.5152\/eurjrheum.2018.18019","article-title":"Anti-Ro antibodies and complete heart block in adults with Sj\u00f6gren\u2019s syndrome","volume":"5","author":"Jobling","year":"2018","journal-title":"Eur. J. Rheumatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/01.CIR.103.11.1599","article-title":"Direct inhibition of expressed cardiac L- and T-type calcium channels by IgG from mothers whose children have congenital heart block","volume":"103","author":"Xiao","year":"2001","journal-title":"Circulation"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/ar3787","article-title":"Congenital heart block: Evidence for a pathogenic role of maternal autoantibodies","volume":"14","author":"Ambrosi","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/pd.5021","article-title":"Serial echocardiography for immune-mediated heart disease in the fetus: Results of a risk-based prospective surveillance strategy","volume":"37","author":"Kan","year":"2017","journal-title":"Prenat. Diagn."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-3083.2010.02443.x","article-title":"Non-cardiac manifestations of neonatal lupus erythematosus","volume":"Volume 72","author":"Silverman","year":"2010","journal-title":"Scandinavian Journal of Immunology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1067\/mpd.2000.109108","article-title":"Cutaneous manifestations of neonatal lupus without heart block: Characteristics of mothers and children enrolled in a national registry","volume":"137","author":"Neiman","year":"2000","journal-title":"J. Pediatr."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.3928\/19382359-20181206-01","article-title":"Common neonatal rashes","volume":"48","author":"Chadha","year":"2019","journal-title":"Pediatr. Ann."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1177\/0961203311430701","article-title":"Facial telangiectasia: An unusual manifestation of neonatal lupus erythematosus","volume":"21","author":"Guinovart","year":"2012","journal-title":"Lupus"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1002\/art.10638","article-title":"Long-term followup of children with neonatal lupus and their unaffected siblings","volume":"46","author":"Martin","year":"2002","journal-title":"Arthritis Rheum."},{"key":"ref_61","unstructured":"Roberts, N.K., and Gelband, H. (1977). Arrhythmias in the neonate. Cardiac Arrhythmias in the Neonate, Infant, and Child, Appleton-Century-Crofts."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00431-016-2748-0","article-title":"Congenital and childhood atrioventricular blocks: Pathophysiology and contemporary management","volume":"175","author":"Baruteau","year":"2016","journal-title":"Eur. J. Pediatr."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Sekar, R. (2019). Hydrops Fetalis. Complications of Pregnancy, IntechOpen.","DOI":"10.5772\/intechopen.83443"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jpedsurg.2014.10.027","article-title":"The many faces of hydrops","volume":"50","author":"Derderian","year":"2015","journal-title":"J. Pediatr. Surg."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/14767050802488220","article-title":"An expanded phenotype of maternal SSASSB antibody-associated fetal cardiac disease","volume":"22","author":"Cuneo","year":"2009","journal-title":"J. Matern. Neonatal Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.amjcard.2010.10.059","article-title":"Spontaneous rupture of atrioventricular valve tensor apparatus as late manifestation of anti-Ro\/SSA antibody-mediated cardiac disease","volume":"107","author":"Cuneo","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijcard.2017.07.100","article-title":"Incidence, risk factors, and mortality of neonatal and late-onset dilated cardiomyopathy associated with cardiac neonatal lupus","volume":"248","author":"Morel","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1191\/0961203302lu173oa","article-title":"Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA\/Ro-SSB\/La antibodies","volume":"11","author":"Askanase","year":"2002","journal-title":"Lupus"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.3899\/jrheum.110720","article-title":"Persistent fetal sinus bradycardia associated with maternal anti-SSA\/Ro and anti-SSB\/La antibodies","volume":"38","author":"Chockalingam","year":"2011","journal-title":"J. Rheumatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0735-1097(00)01048-2","article-title":"Congenital heart block: Development of late-onset cardiomyopathy, a previously underappreciated sequela","volume":"37","author":"Moak","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/hc0702.104182","article-title":"Maternal anti-Ro and anti-La antibody\u2014Associated endocardial fibroelastosis","volume":"105","author":"Nield","year":"2002","journal-title":"Circulation"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1542\/peds.109.1.e11","article-title":"Hepatobiliary disease in neonatal lupus: Prevalence and clinical characteristics in cases enrolled in a national registry","volume":"109","author":"Lee","year":"2002","journal-title":"Pediatrics"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00148581-200406020-00001","article-title":"Neonatal Lupus: Clinical Features and Management","volume":"6","author":"Lee","year":"2004","journal-title":"Pediatr. Drugs"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/j.semperi.2015.03.007","article-title":"Detection of critical congenital heart defects: Review of contributions from prenatal and newborn screening","volume":"39","author":"Olney","year":"2015","journal-title":"Semin. Perinatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1161\/01.cir.0000437597.44550.5d","article-title":"Diagnosis and treatment of fetal cardiac disease: A scientific statement from the american heart association","volume":"129","author":"Donofrio","year":"2014","journal-title":"Circulation"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0002-9149(00)00867-5","article-title":"Pulsed Doppler echocardiographic assessment of the fetal PR interval","volume":"86","author":"Glickstein","year":"2000","journal-title":"Am. J. Cardiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000074256","article-title":"The fetal Doppler mechanical PR interval: A validation study","volume":"19","author":"Glickstein","year":"2004","journal-title":"Fetal Diagn. Ther."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/uog.7333","article-title":"Fetal Doppler mechanical PR interval: Correlation with fetal heart rate, gestational age and fetal sex","volume":"34","author":"Wojakowski","year":"2009","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/CIRCULATIONAHA.107.707661","article-title":"Utility of cardiac monitoring in fetuses at risk for congenital heart block: The PR interval and dexamethasone evaluation (PRIDE) prospective study","volume":"117","author":"Friedman","year":"2008","journal-title":"Circulation"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/bdr2.1459","article-title":"Prenatal diagnosis and management of congenital complete heart block","volume":"111","author":"Pruetz","year":"2019","journal-title":"Birth Defects Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0735-1097(01)01697-7","article-title":"Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block","volume":"39","author":"Jaeggi","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/ro-antibody\u2014Associated cardiac manifestations of neonatal lupus","volume":"126","author":"Izmirly","year":"2012","journal-title":"Circulation"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2009.119263","article-title":"Evaluation of the risk of anti-SSA\/Ro-SSB\/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine","volume":"69","author":"Izmirly","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"Skorpen","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_85","first-page":"172","article-title":"Disease-modifying anti-rheumatic drug use in pregnant women with rheumatic diseases: A systematic review of the risk of congenital malformations","volume":"34","author":"Baldwin","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.jacc.2010.12.014","article-title":"Prolongation of the atrioventricular conduction in fetuses exposed to maternal Anti-Ro\/SSA and Anti-La\/SSB antibodies did not predict progressive heart block: A prospective observational study on the effects of maternal antibodies on 165 fetuses","volume":"57","author":"Jaeggi","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"v9","DOI":"10.1093\/rheumatology\/key141","article-title":"The prevention, screening and treatment ofcongenital heart block from neonatal lupus:a survey of provider practices","volume":"57","author":"Clowse","year":"2018","journal-title":"Rheumatology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1161\/CIRCULATIONAHA.108.773143","article-title":"Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA\/Ro-SSB\/La antibodies a prospective, observational, fetal kinetocardiogram-based study","volume":"119","author":"Rein","year":"2009","journal-title":"Circulation"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/BOR.0b013e32832ed817","article-title":"Prevention of complete heart block in children of mothers with anti-SSA\/Ro and anti-SSB\/La autoantibodies: Detection and treatment of first-degree atrioventricular block","volume":"21","author":"Mevorach","year":"2009","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/aogs.13338","article-title":"Maternal steroid therapy for fetuses with second-degree immune-mediated congenital atrioventricular block: A systematic review and meta-analysis","volume":"97","author":"Ciardulli","year":"2018","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.amjcard.2008.12.027","article-title":"Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study","volume":"103","author":"Friedman","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ajog.2016.07.002","article-title":"Detection and successful treatment of emergent anti-SSA\u2013mediated fetal atrioventricular block","volume":"215","author":"Cuneo","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/jp.2016.220","article-title":"Heart sounds at home: Feasibility of an ambulatory fetal heart rhythm surveillance program for anti-SSA-positive pregnancies","volume":"37","author":"Cuneo","year":"2017","journal-title":"J. Perinatol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10067-016-3174-4","article-title":"Congenital heart block related to maternal autoantibodies: Descriptive analysis of a series of 18 cases from a single center","volume":"35","author":"Doti","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.autrev.2015.08.005","article-title":"Description of 214 cases of autoimmune congenital heart block: Results of the French neonatal lupus syndrome","volume":"14","author":"Levesque","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/annrheumdis-2015-208311","article-title":"Assessment of fluorinated steroids to avert progression and mortality in anti-SSA\/Ro-associated cardiac injury limited to the fetal conduction system","volume":"75","author":"Izmirly","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_97","first-page":"706","article-title":"Plasmapheresis, intravenous immunoglobulins and bethametasone-a combined protocol to treat autoimmune congenital heart block: A prospective cohort study","volume":"34","author":"Ruffatti","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1111\/trf.13046","article-title":"Plasma exchange effectively removes 52- and 60-kDa anti-RO\/SSA and anti-La\/SSB antibodies in pregnant women with congenital heart block","volume":"55","author":"Tonello","year":"2015","journal-title":"Transfusion"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/01.CIR.0000142046.58632.3A","article-title":"Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease","volume":"110","author":"Jaeggi","year":"2004","journal-title":"Circulation"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1017\/S1047951101001123","article-title":"Use of terbutaline in the treatment of complete heart block in the fetus","volume":"11","author":"Robinson","year":"2001","journal-title":"Cardiol. Young"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jtcvs.2010.06.048","article-title":"Fetal surgical management of congenital heart block in a hydropic fetus: Lessons learned from a clinical experience","volume":"141","author":"Eghtesady","year":"2011","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jacc.2018.10.043","article-title":"2018 ACC\/AHA\/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Kusumoto","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijcard.2019.10.008","article-title":"Neonates and infants requiring life-long cardiac pacing: How reliable are epicardial leads through childhood?","volume":"297","author":"Stanner","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_104","first-page":"1","article-title":"Epicardial Pacemaker in Neonates and Infants: Is There a Relationship Between Patient Size, Device Size, and Wound Complicat\u0131on?","volume":"1","author":"Yildiz","year":"2020","journal-title":"Pediatr. Cardiol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1002\/art.27658","article-title":"Identification of candidate loci at 6p21 and 21q22 in a genome-wide association study of cardiac manifestations of neonatal lupus","volume":"62","author":"Clancy","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Manolis, A.A., Manolis, T.A., Melita, H., and Manolis, A.S. (2019). Congenital heart block: Pace earlier (Childhood) than later (Adulthood). Trends in Cardiovascular Medicine, Elsevier Inc.","DOI":"10.1016\/j.tcm.2019.06.006"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"30444","DOI":"10.1074\/jbc.M111.263657","article-title":"A novel role of endothelin-1 in linking toll-like receptor 7-mediated inflammation to fibrosis in congenital heart block","volume":"286","author":"Alvarez","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/annrheumdis-2019-215024","article-title":"Video clip assessment of a salivary gland ultrasound scoring system in Sj\u00f6gren\u2019s syndrome using consensual definitions: An OMERACT ultrasound working group reliability exercise","volume":"78","author":"Nicolas","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"ref_109","unstructured":"Buyon, J. (2020, May 19). Preventive Approach to Congenital Heart Block with Hydroxychloroquine-Study Results-ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT01379573?view=results."},{"key":"ref_110","first-page":"111","article-title":"The prospective open label Preventive Approach to Congenital Heart Block with Hydroxychloroquine (PATCH) Study Demonstrates a Reduction in the recurrence rate of advanced block\u2014Acr meeting abstracts","volume":"71","author":"Izmirly","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0002-9149(01)02130-0","article-title":"Reference values for time intervals between atrial and ventricular contractions of the fetal heart measured by two Doppler techniques","volume":"88","author":"Andelfinger","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/art.20126","article-title":"Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA\/Ro 52-kd antibodies","volume":"50","author":"Sonesson","year":"2004","journal-title":"Arthritis Rheum."},{"key":"ref_113","first-page":"28","article-title":"Fetal dysrhythmias","volume":"Volume 58","author":"Carvalho","year":"2019","journal-title":"Best Practice and Research: Clinical Obstetrics and Gynaecology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/uog.8866","article-title":"Mechanisms in fetal bradyarrhythmia: 65 cases in a single center analyzed by Doppler flow echocardiographic techniques","volume":"37","author":"Eliasson","year":"2011","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-3083.2010.02434.x","article-title":"Diagnosing Foetal Atrioventricular Heart Blocks","volume":"72","author":"Sonesson","year":"2010","journal-title":"Scand. J. Immunol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.7717\/peerj.82","article-title":"What is the \u201cnormal\u201d fetal heart rate?","volume":"1","author":"Boulesteix","year":"2013","journal-title":"PeerJ"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.siny.2005.08.003","article-title":"Fetal brady- and tachyarrhythmias: New and accepted diagnostic and treatment methods","volume":"10","author":"Jaeggi","year":"2005","journal-title":"Semin. Fetal Neonatal Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/1529-0131(200005)43:5<1049::AID-ANR13>3.0.CO;2-X","article-title":"QT interval prolongation in asymptomatic anti-SSA\/Ro-positive infants without congenital heart block","volume":"43","author":"Cimaz","year":"2000","journal-title":"Arthritis Rheum."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/CRD.0b013e31823c808b","article-title":"Cardiac Manifestations of Neonatal Lupus","volume":"20","author":"Capone","year":"2012","journal-title":"Cardiol. Rev."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1540-8159.1999.tb00631.x","article-title":"Altered cardiac histology following apical right ventricular pacing in patients with congenital atrioventricular block","volume":"22","author":"Karpawich","year":"1999","journal-title":"PACE Pacing Clin. Electrophysiol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1540-8167.2006.00741.x","article-title":"Ventricular function and long-term pacing in children with congenital complete atrioventricular block","volume":"18","author":"Kim","year":"2007","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0735-1097(00)01209-2","article-title":"Dilated cardiomyopathy in isolated congenital complete atrioventricular block: Early and long-term risk in children","volume":"37","author":"Breur","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/europace\/euq258","article-title":"Determinants of early dilated cardiomyopathy in neonates with congenital complete atrioventricular block","volume":"12","author":"Silvetti","year":"2010","journal-title":"Europace"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/annrheumdis-2018-214406","article-title":"Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro\/SSA autoantibodies in utero","volume":"78","author":"Mofors","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/art.10700","article-title":"Concomitant disappearance of electrocardiographic abnormalities and of acquired maternal autoantibodies during the first year of life in infants who had QT interval prolongation and anti-SSA\/Ro positivity without congenital heart block at birth","volume":"48","author":"Cimaz","year":"2003","journal-title":"Arthritis Rheum."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00296-016-3488-1","article-title":"Prolonged Tpeak\u2013Tend interval in anti-Ro52 antibody-positive connective tissue diseases","volume":"37","author":"Tufan","year":"2017","journal-title":"Rheumatol. Int."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/acr.20470","article-title":"Prolonged corrected QT interval in anti-Ro\/SSA-positive adults with systemic lupus erythematosus","volume":"63","author":"Clarke","year":"2011","journal-title":"Arthritis Care Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/acr.20540","article-title":"Anti-Ro\/SSA-associated corrected QT interval prolongation in adults: The role of antibody level and specificity","volume":"63","author":"Lazzerini","year":"2011","journal-title":"Arthritis Care Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fcvm.2015.00026","article-title":"Long QT syndrome: An emerging role for inflammation and immunity","volume":"2","author":"Lazzerini","year":"2015","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e010595","DOI":"10.1161\/JAHA.118.010595","article-title":"Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies","volume":"7","author":"Lazzerini","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1017\/S1047951105000673","article-title":"Ventricular tachycardia secondary to prolongation of the QT interval in a fetus with autoimmune mediated congenital complete heart block","volume":"15","author":"Duke","year":"2005","journal-title":"Cardiol. Young"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.jacc.2007.07.037","article-title":"Anti-KCNH2 antibody-induced long QT syndrome. Novel acquired form of long QT syndrome","volume":"50","author":"Nakamura","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"H2017","DOI":"10.1152\/ajpheart.00537.2008","article-title":"Impaired Ca2+ homeostasis is associated with atrial fibrillation in the \u03b11D L-type Ca2+ channel KO mouse","volume":"295","author":"Mancarella","year":"2008","journal-title":"Am. J. Physiol. Hear. Circ. Physiol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1651-2227.2011.02563.x","article-title":"Progression to first-degree heart block in preschool children exposed in utero to maternal anti-SSA\/Ro52 autoantibodies","volume":"101","author":"Bergman","year":"2012","journal-title":"Acta Paediatr."},{"key":"ref_135","first-page":"293","article-title":"Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro\/SSA-associated cases","volume":"1","author":"Lazzerini","year":"2015","journal-title":"Hear. Case Rep."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3899\/jrheum.180526","article-title":"Effect on cardiac function of longstanding juvenile-onset mixed connective tissue disease: A controlled study","volume":"46","author":"Witczak","year":"2019","journal-title":"J. Rheumatol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10238-019-00600-8","article-title":"Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease","volume":"20","author":"Leone","year":"2020","journal-title":"Clin. Exp. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00246-019-02107-1","article-title":"Echocardiographic Assessment of Diastolic Function in Children with Incident Systemic Lupus Erythematosus","volume":"40","author":"Chang","year":"2019","journal-title":"Pediatr. Cardiol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1093\/eurheartj\/ehz641","article-title":"How to diagnose heart failure with preserved ejection fraction: The HFA-PEFF diagnostic algorithm: A consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) Heart failure\/cardiomyopathy","volume":"40","author":"Pieske","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.jacc.2017.08.074","article-title":"Heart failure with preserved, borderline, and reduced ejection fraction 5-year outcomes","volume":"70","author":"Shah","year":"2017","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/10\/7\/478\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:51:27Z","timestamp":1760176287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/10\/7\/478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":140,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["diagnostics10070478"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics10070478","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,14]]}}}